Impaired P2X1 receptor-mediated adhesion in eosinophils from asthmatic patients

Impaired P2X1 receptor-mediated adhesion in eosinophils from asthmatic patients

Eosinophils play an important role in the pathogenesis of asthma and can be activated by extracellular nucleotides released following cell damage or inflammation. For example, increased ATP concentrations were reported in bronchoalveolar lavage fluids of asthmatic patients. Although eosinophils are...

Полное описание

Библиографические подробности
Главные авторы:	Wright, A, Mahaut-Smith, M, Symon, F, Sylvius, N, Ran, S, Bafadhel, M, Muessel, M, Bradding, P, Wardlaw, A, Vial, C
Формат:	Journal article
Язык:	English
Опубликовано:	American Association of Immunologists 2016

Схожие документы

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
по: Brightling, C, и др.
Опубликовано: (2003)

TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
по: Brightling, C, и др.
Опубликовано: (2002)

Mepolizumab in refractory eosinophilic asthma.
по: Pavord, I, и др.
Опубликовано: (2010)

IL-13 expression by blood T cells and not eosinophils is increased in asthma compared to non-asthmatic eosinophilic bronchitis
по: Mistry Vijay, и др.
Опубликовано: (2009-07-01)

Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma
по: Shrimanker, R, и др.
Опубликовано: (2017)

Eotaxin and the attraction of eosinophils to the asthmatic lung
по: Williams Timothy J, и др.
Опубликовано: (2001-03-01)

Characterisation of exacerbations of severe eosinophilic asthma (SEA) on mepolizumab compared to placebo
по: Shrimanker, R, и др.
Опубликовано: (2017)

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.
по: Berry, M, и др.
Опубликовано: (2007)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
по: Eltboli, O, и др.
Опубликовано: (2014)

Eosinophil Progenitors in Patients With Non-Asthmatic Eosinophilic Bronchitis, Eosinophilic Asthma, and Normal Controls
по: Chen Zhan, и др.
Опубликовано: (2022-03-01)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients
по: Ilknur Basyigit, и др.
Опубликовано: (2004-01-01)

IL-4-expressing bronchoalveolar T cells from asthmatic and healthy subjects preferentially express CCR 3 and CCR 4.
по: Morgan, A, и др.
Опубликовано: (2005)

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
по: Hambleton, K, и др.
Опубликовано: (2017)

Evaluation Role of IL-13 and Eosinophils in Adult Asthmatic Patients
по: Meraim A. Kazaal, и др.
Опубликовано: (2023-06-01)

Mepolizumab and exacerbations of refractory eosinophilic asthma.
по: Haldar, P, и др.
Опубликовано: (2009)

Asthma: Eosinophil Disease, Mast Cell Disease, or Both?
по: Bradding Peter
Опубликовано: (2008-06-01)

Serum cytokines and treatment response in atopic and non-atopic eosinophilic asthmatics
по: Jamille Fernandes, и др.
Опубликовано: (2020-08-01)

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.
по: Green, R, и др.
Опубликовано: (2002)

Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis.
по: Berry, M, и др.
Опубликовано: (2004)

Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis.
по: Siddiqui, S, и др.
Опубликовано: (2007)

Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: A 12-month follow-up analysis
по: Haldar, P, и др.
Опубликовано: (2014)

The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects
по: J. Grzegorczyk, и др.
Опубликовано: (2000-01-01)

Objective quantitative analysis of eosinophils and bronchial epithelial cells in induced sputum by laser scanning cytometry.
по: Woltmann, G, и др.
Опубликовано: (1999)

Eosinophils in COPD: just another biomarker?
по: Bafadhel, M, и др.
Опубликовано: (2017)

Investigating blood eosinophil count thresholds in patients with COPD
по: Russell, R, и др.
Опубликовано: (2018)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
по: Brightling, C, и др.
Опубликовано: (2003)

Mast-cell infiltration of airway smooth muscle in asthma.
по: Brightling, C, и др.
Опубликовано: (2002)

Characterising non-eosinophilic COPD
по: Hambleton, K, и др.
Опубликовано: (2015)

Identifying clinical and demographic characteristic differences between eosinophilic and non-eosinophilic asthma and detecting predictors of eosinophilic asthma among Egyptian asthmatic patients
по: Maged Mohamed Refaat, и др.
Опубликовано: (2022-10-01)

The role of oral methotrexate as a steroid sparing agent in refractory eosinophilic asthma.
по: Bilocca, D, и др.
Опубликовано: (2017)

Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?
по: Sophie F. Demarche, и др.
Опубликовано: (2017-07-01)

Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.
по: Mahajan, L, и др.
Опубликовано: (2008)

Role of Adhesion Molecules in Eosinophil Activation: A Comparative Study on the Effect of Adhesion Molecules on Eosinophil Survival
по: Kazutoshi Yamaguchi, и др.
Опубликовано: (2004-01-01)

Eosinophil migration is enhanced towards IL-5 and eotaxin in COPD
по: Lababidi, R, и др.
Опубликовано: (2017)

Association between protein intake, serum albumin and blood eosinophil in US asthmatic adults
по: Jun Wen, и др.
Опубликовано: (2024-05-01)

Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients
по: Patrizia Pignatti, и др.
Опубликовано: (2019-07-01)

Relationship between triglyceride-glucose index and blood eosinophils among asthmatic individuals in the USA
по: Jun Wen, и др.
Опубликовано: (2024-05-01)

Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
по: Saunders, R, и др.
Опубликовано: (2017)

Fevipiprant reduced airway smooth muscle massin asthmatics via PGD2Receptor antagonism
по: Saunders, R, и др.
Опубликовано: (2017)

The significance of eosinophilic airway inflammation in asthma
по: Pavord, I, и др.
Опубликовано: (2002)